PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
In alloxan-induced diabetic mice, T. pallida leaf extract (50 mg/kg) and phytoniosomes (25 and 50 mg/kg) remarkably reduced blood glucose levels [PMID: 36856606].
Aqueous extracts significantly inhibited bacterial growth and biofilm formation [PMID: 31579334].
Evidence summary
PubMed sources
- 1.PMID: 31579334 (2019) — Tradescantia pallida extract inhibits biofilm formation in Pseudomonas aeruginosa. · Nagoya journal of medical science
- 2.PMID: 36559071 (2022) — Prediction of α-Glucosidase Inhibitory Activity of LC-ESI-TQ-MS/MS-Identified Compounds from Tradescantia pallida Leaves. · Pharmaceutics
- 3.PMID: 36597930 (2023) — Phenolic compounds from Tradescantia pallida ameliorate diabetes by inhibiting enzymatic and non-enzymatic pathways. · Journal of biomolecular structure & dynamics
- 4.PMID: 32419482 (2022) — Chemical composition of Tradescantia pallida (Rose) D.R. Hunt var. purpurea Boom (Commelinaceae) essential oil. · Natural product research
- 5.PMID: 36907011 (2023)